Focus on hospira vulnerabilities and metrics.
Last updated: 08 Mar 2025, 23:25 UTC
This page consolidates all known Common Vulnerabilities and Exposures (CVEs) associated with hospira. We track both calendar-based metrics (using fixed periods) and rolling metrics (using gliding windows) to give you a comprehensive view of security trends and risk evolution. Use these insights to assess risk and plan your patching strategy.
For a broader perspective on cybersecurity threats, explore the comprehensive list of CVEs by vendor and product. Stay updated on critical vulnerabilities affecting major software and hardware providers.
Total hospira CVEs: 11
Earliest CVE date: 03 Apr 2015, 10:59 UTC
Latest CVE date: 26 Mar 2019, 17:29 UTC
Latest CVE reference: CVE-2014-5401
30-day Count (Rolling): 0
365-day Count (Rolling): 0
Calendar-based Variation
Calendar-based Variation compares a fixed calendar period (e.g., this month versus the same month last year), while Rolling Growth Rate uses a continuous window (e.g., last 30 days versus the previous 30 days) to capture trends independent of calendar boundaries.
Month Variation (Calendar): 0%
Year Variation (Calendar): 0%
Month Growth Rate (30-day Rolling): 0.0%
Year Growth Rate (365-day Rolling): 0.0%
Average CVSS: 7.3
Max CVSS: 10.0
Critical CVEs (≥9): 5
| Range | Count |
|---|---|
| 0.0-3.9 | 1 |
| 4.0-6.9 | 3 |
| 7.0-8.9 | 2 |
| 9.0-10.0 | 5 |
These are the five CVEs with the highest CVSS scores for hospira, sorted by severity first and recency.
Hospira MedNet software version 5.8 and prior uses vulnerable versions of the JBoss Enterprise Application Platform software that may allow unauthenticated users to execute arbitrary code on the target system. Hospira has developed a new version of the MedNet software, MedNet 6.1. Existing versions of MedNet can be upgraded to MedNet 6.1.
Stack-based buffer overflow in Hospira Communication Engine (CE) before 1.2 in LifeCare PCA Infusion System 5.07, Plum A+ Infusion System 13.40, and Plum A+3 Infusion System 13.40 allows remote attackers to cause a denial of service or possibly have unspecified other impact via traffic on TCP port 5000.
Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP packets.
Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.
Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to execute arbitrary code via unspecified vectors.
Hospira LifeCare PCA Infusion System before 7.0 has hardcoded credentials, which makes it easier for remote attackers to obtain access via unspecified vectors.
The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.
The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for root TELNET sessions, which allows remote attackers to modify the pump configuration via unspecified commands.
Hospira MedNet before 6.1 uses a hardcoded cleartext password to control SQL database authorization, which allows remote authenticated users to bypass intended access restrictions by leveraging knowledge of this password.
Hospira MedNet before 6.1 uses hardcoded cryptographic keys for protection of data transmission from infusion pumps, which allows remote attackers to obtain sensitive information by sniffing the network.
The installation component in Hospira MedNet before 6.1 places cleartext credentials in configuration files, which allows local users to obtain sensitive information by reading a file.